Brian Leedman

Brian Leedman is a marketing and investor relations professional with over 15 years’ experience in the biotechnology industry and an experienced company director. Mr Leedman was co-founder of ResApp Diagnostics Pty Ltd which was acquired by Narhex Life Sciences Ltd to form ResApp Health. Mr Leedman is the Chairman of ASX listed Nutritional Growth Solutions and Neurotech International and co-founded Oncosil Medical Limited and Biolife Science Limited (acquired by Imugene Limited). Mr Leedman is previously the Chairman of NeuroScientific Biopharmaceuticals Limited, Non-executive Director of Alcidian Limited and Chairman (WA) of Ausbiotech, the industry association of biotechnology companies. He served for 10 years as Vice President, Investor Relations for pSivida Corp. (changed name to Eyepoint Pharma) which is listed on the NASDAQ.

Mr Leedman holds a Bachelor of Economics and a Master of Business Administration from the University of Western Australia.